Lorcaserin Treatment for Extended-Release Naltrexone Induction and Retention for Opioid Use Disorder Individuals: A Pilot, Randomized Trial

BACKGROUND: Opioid Use Disorder (OUD) is a significant public health problem associated with severe morbidity and mortality. While effective pharmacotherapies are available, limitations exist with each. Induction onto extended-release naltrexone (XR-NTX) is more difficult than initiation of buprenor...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Alcohol Depend
Prif Awduron: Levin, Frances R., Mariani, John J., Pavlicova, Martina, Choi, C. Jean, Basaraba, Cale, Mahony, Amy L., Brooks, Daniel J., Naqvi, Nasir, Bisaga, Adam
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856237/
https://ncbi.nlm.nih.gov/pubmed/33418204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108482
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg